BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11359952)

  • 1. The molecular perspective: cytochrome P450.
    Goodsell DS
    Stem Cells; 2001; 19(3):263-4. PubMed ID: 11359952
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochrome p450 in silico: an integrative modeling approach.
    de Graaf C; Vermeulen NP; Feenstra KA
    J Med Chem; 2005 Apr; 48(8):2725-55. PubMed ID: 15828810
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytochrome p450 conformational diversity.
    Stout CD
    Structure; 2004 Nov; 12(11):1921-2. PubMed ID: 15530355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical perspective on the structure and mechanism of cytochrome P450 enzymes.
    Shaik S; Kumar D; de Visser SP; Altun A; Thiel W
    Chem Rev; 2005 Jun; 105(6):2279-328. PubMed ID: 15941215
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytochromes P450 and drug discovery.
    Lamb DC; Waterman MR; Kelly SL; Guengerich FP
    Curr Opin Biotechnol; 2007 Dec; 18(6):504-12. PubMed ID: 18006294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charge-dependent sidedness of cytochrome P450 forms studied by quartz crystal microbalance and atomic force microscopy.
    Schenkman JB; Jansson I; Lvov Y; Rusling JF; Boussaad S; Tao NJ
    Arch Biochem Biophys; 2001 Jan; 385(1):78-87. PubMed ID: 11361029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking.
    Li W; Tang Y; Liu H; Cheng J; Zhu W; Jiang H
    Proteins; 2008 May; 71(2):938-49. PubMed ID: 18004755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resonance surface plasmon spectroscopy: low molecular weight substrate binding to cytochrome p450.
    Zhao J; Das A; Zhang X; Schatz GC; Sligar SG; Van Duyne RP
    J Am Chem Soc; 2006 Aug; 128(34):11004-5. PubMed ID: 16925400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity of a new class of P450 enzyme models.
    Meyer D; Leifels T; Sbaragli L; Woggon WD
    Biochem Biophys Res Commun; 2005 Dec; 338(1):372-7. PubMed ID: 16111653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermophilic cytochrome P450 enzymes.
    Nishida CR; Ortiz de Montellano PR
    Biochem Biophys Res Commun; 2005 Dec; 338(1):437-45. PubMed ID: 16139791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QM/MM modeling of compound I active species in cytochrome P450, cytochrome C peroxidase, and ascorbate peroxidase.
    Harvey JN; Bathelt CM; Mulholland AJ
    J Comput Chem; 2006 Sep; 27(12):1352-62. PubMed ID: 16788912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first structure of a microsomal P450--implications for drug discovery.
    Tennant M; McRee DE
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):671-7. PubMed ID: 12825462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 Cyp4x1 is a major P450 protein in mouse brain.
    Al-Anizy M; Horley NJ; Kuo CW; Gillett LC; Laughton CA; Kendall D; Barrett DA; Parker T; Bell DR
    FEBS J; 2006 Mar; 273(5):936-47. PubMed ID: 16478468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput carbon monoxide binding assay for cytochromes p450.
    Otey CR
    Methods Mol Biol; 2003; 230():137-9. PubMed ID: 12824576
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of drug-like molecular properties: modeling cytochrome p450 interactions.
    Jalaie M; Arimoto R; Gifford E; Schefzick S; Waller CL
    Methods Mol Biol; 2004; 275():449-520. PubMed ID: 15141126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of CYP199A2, a para-substituted benzoic acid oxidizing cytochrome P450 from Rhodopseudomonas palustris.
    Bell SG; Xu F; Forward I; Bartlam M; Rao Z; Wong LL
    J Mol Biol; 2008 Nov; 383(3):561-74. PubMed ID: 18762195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 enzymes.
    Donaldson D
    J R Soc Promot Health; 2000 Sep; 120(3):150-1. PubMed ID: 11077800
    [No Abstract]   [Full Text] [Related]  

  • 19. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF; Jacobs MN; Dickins M
    Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein dynamics and imidazole binding in cytochrome P450 enzymes.
    Verras A; Ortiz de Montellano PR
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1170-2. PubMed ID: 17073778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.